Telix Pharmaceuticals Ltd (ASX: TLX) has announced a $200m capital raise
Telix Pharmaceuticals Ltd (ASX: TLX) has announced the launch of a capital raise through conducting the Offer to raise $200m comprising an institutional placement to raise $175m and a share purchase plan to raise up to $25m. The capital raise will be used to fund late-stage clinical programs and pipeline expansion
When an ASX-listed company announces a capital raising, it generally means it is selling more shares to raise money.
More often than not, the shares are sold at a discount to the company’s share price at the time to entice new and existing investors.
Following the announcement, shares in Telix Pharmaceuticals Ltd traded 11% lower at $7.20/share.
Read the full story
in the Grafa app
To read the full article and more in the Grafa app, available on all app stores.
Track the trends
Get the hot tips first
Stay close to your investments
Learn to trade like a pro
Let your money entertain you
See more stories like this
48% of businesses say they will not raise prices, primarily due to the desire to...read more